Broker recommendations for Mizuho Financial Group
The Mizuho Financial Group, Inc. stock is rated at 1.958333 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Monday 27 July, 2020 by a total of 12 brokers. This means that the consensus of the 12 different brokers is leaning toward to hold.
Sell
1 (8.33%) Underweight
0 (0%) Hold
9 (75%) Overweight
1 (8.33%) Buy
1 (8.33%)
Price target by analysts
The 11 latest analyst estimates, per Tuesday 11 August, 2020, show the following high, low and average price targets.
Target Average: 3.03 USD
Target High: 4.36 USD
Target Low: 2.27 USD
Magellan’s twin wealth builders
Wednesday, 12 August 2020, 16:00:00
Hamish Douglass at Magellan Financial Group keeps coming up with new ways to grow funds under management. His latest bold move will disrupt his core business.
— The Australian Financial Review
ASX:MFG – Dividend/Distribution – MFG | MarketScreener
Wednesday, 12 August 2020, 06:28:03
Notification of dividend / distribution Announcement Summary Entity name MAGELLAN FINANCIAL GROUP LIMITED … | August 12, 2020
— MarketScreener
The Magellan Financial Group (ASX:MFG) sees full year adjusted profit rise 20%
Wednesday, 12 August 2020, 03:56:08
12 Aug 2020 – The Magellan Financial Group (ASX:MFG) today announced adjusted after-tax net profit increased by 20 per cent to $438.3 million for the 12 months to 30 June 2020.
— Finance News Network
ASX:MFG – Funds Under Management – July 2020 | MarketScreener
Friday, 7 August 2020, 02:29:24
MAGELLAN FINANCIAL GROUP LIMITED FUNDS UNDER MANAGEMENT UPDATE1 AS AT 31 JULY 2020 … | August 7, 2020
— MarketScreener
Pfizer’s (PFE) CEO Albert Bourla on Q2 2020 Results – Earnings Call Transcript
Wednesday, 29 July 2020, 01:46:07
Pfizer, Inc. (NYSE:PFE) Q2 2020 Earnings Conference Call July 28, 2020 10:00 AM ET Company Participants Chuck Triano – Senior Vice President-Investor Relations Albert Bourla – Chairman and Chief Executive Offier Frank D’Amelio – Chief Financial Officer Mikael Dolsten – President-Worldwide Research and Development Angela Hwang – Group President-Pfizer Biopharmaceuticals Group John Young – Chief Business Officer Doug Lankler – General Counsel Conference Call Participants Steve Scala – Cowen Tim Anderson – Wolfe Research Vamil Divan – Mizuho Securities Randall Stanicky – RBC Capital Markets Terence Flynn – Goldman Sachs Louise Chen – Cantor Chris Schott – JP Morgan Umer Raffat – Evercore David Risinger – Morgan Stanley Geoffrey Porges – SVB Leerink Presentation Operator Good day, everyone, and welcome to Pfizer’s Second Quarter 2020 Earnings Conference Call.
— Seeking Alpha
